By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Pharmaceutical research and development and related business activities3.98B100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Asia2.05B51.54%
Japan1.07B26.82%
United States861M21.63%
